Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCFO4Life Group, LLC
Latest Disclosed Ownership3,154 shares
Latest Disclosed Value $ 439,586
CFO4Life Group, LLC reports 15.69% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - CFO4Life Group, LLC filed a 13F-HR form disclosing ownership of 3,154 shares of Gilead Sciences, Inc. (CH:GILD) valued at $439,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 3,741 shares of Gilead Sciences, Inc.. This represents a change in shares of -15.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F GILEAD SCIENCES COM 375558103 3,154 -587 -15.69 440 -4.36 0.0670
2026-02-06 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,741 -39 -1.03 459 9.55 0.0655
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,780 34 0.91 420 0.96 0.0610
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 3,746 30 0.81 415 -0.24 0.0649
2025-04-30 2025-03-31 13F GILEAD SCIENCES COM 375558103 3,716 -549 -12.87 416 5.85 0.0701
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 4,265 112 2.70 394 12.93 0.0692
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,153 -1,749 -29.63 348 -13.86 0.0616
2024-07-31 2024-06-30 13F GILEAD SCIENCES COM 375558103 5,902 83 1.43 405 -5.16 0.0761
2024-05-06 2024-03-31 13F GILEAD SCIENCES COM 375558103 5,819 -3,502 -37.57 426 -43.58 0.0774
2024-02-12 2023-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 9,321 -3,925 -29.63 755 -23.89 0.1442
2024-01-24 2023-12-31 13F GILEAD SCIENCES COM 375558103 9,321 -3,925 755 0.1442
2023-10-30 2023-09-30 13F GILEAD SCIENCES COM 375558103 13,246 -1,434 -9.77 993 -12.29 0.2292
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 14,680 3,489 31.18 1,131 21.88 0.2428
2023-05-03 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,191 -79 -0.70 929 -4.03 0.2110
2023-02-03 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,270 -3,229 -22.27 968 8.17 0.2056
2022-10-19 2022-09-30 13F GILEAD SCIENCES COM 375558103 14,499 -288 -1.95 894 -0.78 0.2379
2022-07-20 2022-06-30 13F GILEAD SCIENCES COM 375558103 14,787 302 2.08 901 4.65 0.2236
2022-05-02 2022-03-31 13F GILEAD SCIENCES COM 375558103 14,485 -269 -1.82 861 -19.61 0.1807
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 14,754 14,754 1,071 0.2214
2020-10-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,531 -100.00 0 -100.00
2020-07-15 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,531 -1,153 -24.62 272 -22.29 0.1045
2020-04-16 2020-03-31 13F GILEAD SCIENCES COM 375558103 4,684 -1,528 -24.60 350 -13.37 0.1872
2020-01-22 2019-12-31 13F GILEAD SCIENCES COM 375558103 6,212 138 2.27 404 4.94 0.1708
2019-11-01 2019-09-30 13F GILEAD SCIENCES COM 375558103 6,074 38 0.63 385 -5.64 0.1726
2019-07-29 2019-06-30 13F GILEAD SCIENCES COM 375558103 6,036 952 18.73 408 23.26 0.1865
2019-04-22 2019-03-31 13F GILEAD SCIENCES COM 375558103 5,084 -858 -14.44 331 -11.02 0.1551
2019-02-01 2018-12-31 13F GILEAD SCIENCES COM 375558103 5,942 29 0.49 372 -18.60 0.1636
2018-10-25 2018-09-30 13F GILEAD SCIENCES COM 375558103 5,913 -70 -1.17 457 7.78 0.2026
2018-08-01 2018-06-30 13F GILEAD SCIENCES COM 375558103 5,983 -1,600 -21.10 424 -25.87 0.1769
2018-05-07 2018-03-31 13F GILEAD SCIENCES COM 375558103 7,583 26 0.34 572 5.73 0.4836
2018-01-22 2017-12-31 13F GILEAD SCIENCES COM 375558103 7,557 -2,538 -25.14 541 -33.86 0.4253
2017-11-09 2017-09-30 13F GILEAD SCIENCES COM 375558103 10,095 -334 -3.20 818 10.84 0.6596
2017-08-08 2017-06-30 13F GILEAD SCIENCES COM 375558103 10,429 317 3.13 738 7.42 0.6796
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 10,112 10,112 687 0.6232
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.